Literature DB >> 18308213

Outcomes of bacteremia in burn patients involved in combat operations overseas.

Roseanne A Ressner1, Clinton K Murray, Matthew E Griffith, Mark S Rasnake, Duane R Hospenthal, Steven E Wolf.   

Abstract

BACKGROUND: Burn patients constitute approximately 5% of casualties injured in support of US military operations in Iraq (Operation Iraqi Freedom [OIF]) and Afghanistan (Operation Enduring Freedom [OEF]). Since the onset of these conflicts, there have been numerous casualties infected with multidrug-resistant bacteria. It is currently unclear if bacteremia with these multidrug-resistant organisms in OIF/OEF burn casualties is associated with increased mortality. STUDY
DESIGN: We performed a retrospective cohort study of all patients admitted to the US Army Institute of Surgical Research burn center from January 2003 to May 2006 to evaluate bacteremia in our burn-patient population.
RESULTS: One hundred twenty-nine of 1,258 patients admitted to the burn center became bacteremic during their hospitalization. Of these, 92 had bacteremia with the top four pathogens in our burn center, ie, Pseudomonas aeruginosa, Klebsiella pneumoniae, Acinetobacter calcoaceticus-baumannii complex, and Staphylococcus aureus. Presence of any bacteremia was associated with mortality and increased ventilator days. Bacteremia with K pneumoniae was associated with a statistically increased mortality and a prolonged ventilator course relative to all other pathogens.
CONCLUSIONS: Casualties of OIF/OEF with burn injuries did not have different outcomes than patients whose burns were not associated with military operations. Bacteremia, especially with a multidrug-resistant organism, causes increased mortality in burn patients. Of all the pathogens causing bacteremia, K pneumonia appears to have the greatest impact on mortality.

Entities:  

Mesh:

Year:  2007        PMID: 18308213     DOI: 10.1016/j.jamcollsurg.2007.09.017

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  18 in total

1.  Photodynamic therapy for Acinetobacter baumannii burn infections in mice.

Authors:  Tianhong Dai; George P Tegos; Zongshun Lu; Liyi Huang; Timur Zhiyentayev; Michael J Franklin; David G Baer; Michael R Hamblin
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

2.  Sublethal concentrations of carbapenems alter cell morphology and genomic expression of Klebsiella pneumoniae biofilms.

Authors:  Tricia A Van Laar; Tsute Chen; Tao You; Kai P Leung
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

3. 

Authors:  S Frigui; Y Bourbiaa; A Mokline; H Naija; A A Messadi; L Thabet
Journal:  Ann Burns Fire Disasters       Date:  2021-03-31

4.  Tunable engineered skin mechanics via coaxial electrospun fiber core diameter.

Authors:  Britani Nicole Blackstone; Jason William Drexler; Heather Megan Powell
Journal:  Tissue Eng Part A       Date:  2014-05-20       Impact factor: 3.845

Review 5.  The route less taken: pulmonary models of enteric Gram-negative infection.

Authors:  Michael L Fisher; Wei Sun; Roy Curtiss
Journal:  Pathog Dis       Date:  2013-11-21       Impact factor: 3.166

Review 6.  Prophylactic antibiotics for burns patients: systematic review and meta-analysis.

Authors:  Tomer Avni; Ariela Levcovich; Dean D Ad-El; Leonard Leibovici; Mical Paul
Journal:  BMJ       Date:  2010-02-15

7.  The epidemiology of methicillin-resistant Staphylococcus aureus on a burn trauma unit.

Authors:  Marin Schweizer; Melissa Ward; Sandra Cobb; Jennifer McDanel; Laurie Leder; Lucy Wibbenmeyer; Barbara Latenser; Daniel Diekema; Loreen Herwaldt
Journal:  Infect Control Hosp Epidemiol       Date:  2012-09-21       Impact factor: 3.254

8.  Activity of imipenem against Klebsiella pneumoniae biofilms in vitro and in vivo.

Authors:  Ping Chen; Akhil K Seth; Johnathan J Abercrombie; Thomas A Mustoe; Kai P Leung
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

9.  Mortality incidence among critically ill burn patients infected with multidrug-resistant organisms: A retrospective cohort study.

Authors:  Moustafa Ellithy; Hassan Mitwally; Mohamed Saad; Ranjan Mathias; Adila Shaukat; Hani Elzeer; Sunil Hassan Koya; Zia Mahmood; Khaled Gazwi
Journal:  Scars Burn Heal       Date:  2021-05-25

10.  The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds.

Authors:  Allen J Duplantier; Monique L van Hoek
Journal:  Front Immunol       Date:  2013-07-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.